NCT06890078 Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
| NCT ID | NCT06890078 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Pneumocystis |
| Study Type | OBSERVATIONAL |
| Enrollment | 240 participants |
| Start Date | 2025-07-08 |
| Primary Completion | 2027-07-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 240 participants in total. It began in 2025-07-08 with a primary completion date of 2027-07-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Eligibility Criteria
Inclusion Criteria: * adult patients with suspected pneumocystis * with an indication for bronchial fibroscopy for BAL or induced sputum * no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition Exclusion Criteria: * Pneumocystis treated for more than 72 hours * pregnancy/breast-feeding * adult patients deprived of liberty, protected
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06890078 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pneumocystis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06890078 currently recruiting?
Yes, NCT06890078 is actively recruiting participants. Contact the research team at agathelaure.vigouroux@aphp.fr for enrollment information.
Where is the NCT06890078 trial being conducted?
This trial is being conducted at Paris, France, Paris, France, Paris, France, Paris, France.
Who is sponsoring the NCT06890078 clinical trial?
NCT06890078 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 240 participants.